CN101378762A - 一种治疗急性血管疾病的方法 - Google Patents

一种治疗急性血管疾病的方法 Download PDF

Info

Publication number
CN101378762A
CN101378762A CNA2007800045937A CN200780004593A CN101378762A CN 101378762 A CN101378762 A CN 101378762A CN A2007800045937 A CNA2007800045937 A CN A2007800045937A CN 200780004593 A CN200780004593 A CN 200780004593A CN 101378762 A CN101378762 A CN 101378762A
Authority
CN
China
Prior art keywords
steroid
acute
group
disease
estetrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800045937A
Other languages
English (en)
Chinese (zh)
Inventor
H·J·T·C·本宁克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Publication of CN101378762A publication Critical patent/CN101378762A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
CNA2007800045937A 2006-01-09 2007-01-09 一种治疗急性血管疾病的方法 Pending CN101378762A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06100159.0 2006-01-09
EP06100159 2006-01-09
US60/757,027 2006-01-09

Publications (1)

Publication Number Publication Date
CN101378762A true CN101378762A (zh) 2009-03-04

Family

ID=36100928

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800045937A Pending CN101378762A (zh) 2006-01-09 2007-01-09 一种治疗急性血管疾病的方法

Country Status (4)

Country Link
CN (1) CN101378762A (de)
AT (1) ATE481973T1 (de)
DE (1) DE602007009358D1 (de)
ES (1) ES2352547T3 (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107771075A (zh) * 2015-06-18 2018-03-06 密特拉制药公司 含雌四醇组分的口腔分散剂量单位
US11666585B2 (en) 2018-04-19 2023-06-06 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US11896602B2 (en) 2016-08-05 2024-02-13 Estetra Srl Method for preventing pregnancy
US11964055B2 (en) 2015-06-18 2024-04-23 Estetra Srl Orodispersible dosage unit containing an estetrol component
US12458649B2 (en) 2020-04-16 2025-11-04 Estetra Srl Contraceptive compositions with reduced adverse effects

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107771075A (zh) * 2015-06-18 2018-03-06 密特拉制药公司 含雌四醇组分的口腔分散剂量单位
US11964055B2 (en) 2015-06-18 2024-04-23 Estetra Srl Orodispersible dosage unit containing an estetrol component
US11896602B2 (en) 2016-08-05 2024-02-13 Estetra Srl Method for preventing pregnancy
US11666585B2 (en) 2018-04-19 2023-06-06 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12390478B2 (en) 2018-04-19 2025-08-19 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12458651B2 (en) 2018-04-19 2025-11-04 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12458649B2 (en) 2020-04-16 2025-11-04 Estetra Srl Contraceptive compositions with reduced adverse effects

Also Published As

Publication number Publication date
ES2352547T3 (es) 2011-02-21
ATE481973T1 (de) 2010-10-15
DE602007009358D1 (de) 2010-11-04

Similar Documents

Publication Publication Date Title
EP1971344B1 (de) Verfahren zur behandlung einer akuten gefässerkrankung
Nguyen et al. Erectile dysfunction in young men—a review of the prevalence and risk factors
Kaunitz et al. Management of menopausal symptoms
US6100286A (en) Methods and formulations for modulating the human sexual response
Coutinho et al. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive: A multicenter, international, dose-finding study
EP1028720A1 (de) Methoden, zusammenstellungen und sets zur steigerung des weiblichen sexualdrangs und der sexuellen empfänglichkeit
CN101378762A (zh) 一种治疗急性血管疾病的方法
Patel Recent Trends in Medical Management of Endometriosis: M. Patel
CN111295192A (zh) 用于前列腺癌治疗的辅助疗法
Yap et al. Topical agents and erectile dysfunction: is there a place?
Marcon et al. Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie’s Disease
Wylie et al. Erectile dysfunction
Kozan et al. Pharmacology of Male Sexual Function
Singh et al. Erectile dysfunction
Wang et al. Current Management of Erectile Dysfunction
Kelkar Dysfunction of Sexual and Accessory Sex Organs
Najjar Depression and Heart Failure in Male and Female Rats: Role of Inflammation and Estrogens
Lunenfeld et al. Erectile dysfunction in the aging male
Lue MEDICAL AND SURGICAL THERAPY OF ERECTILE DYSFUNCTION
Manassiev et al. Menopause, hormone replacement therapy and non-hormonal strategies
MX2015001644A (es) Ligandos del receptor de adenosina a3 para su uso en el tratamiento de una disfuncion sexual.
JP2005220052A (ja) 性機能障害治療用外用剤
Gallina et al. Erectile dysfunction in the aging male
Parisi et al. Sex and Pharmacological Sexual Enhancement
Brant et al. 8.1. PHYSIOLOGY OF ERECTIONS

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20090304